What is Sampling Human?
Sampling Human, Inc. is a synthetic biology diagnostics company focused on pioneering novel methods for the early detection of diseases. The company has engineered accessible diagnostic reagent kits for liquid biopsies, capable of analyzing both healthy and diseased cells. Their proprietary technology harnesses living cells to perform cellular analysis, aiming to elevate sensitivity and speed beyond the capabilities of complex instruments like flow cytometry. Sampling Human's "Diagnostics On Target" (DOT) platform represents a next-generation cell diagnostics technology designed to translate extensive single-cell data into actionable clinical insights for improved early disease detection and treatment monitoring.
How much funding has Sampling Human raised?
Sampling Human has raised a total of $2M across 1 funding round:
Other Financing Round
$2M
Other Financing Round (2022): $2M with participation from i&i Biotech Fund, Formic Ventures, and Longevitytech.Fund
Key Investors in Sampling Human
Longevitytech.Fund
Longevitytech.Fund is focused on global investments in technologies that aim to extend healthy lifespans. The company seeks to support innovations that contribute to longevity and improved health outcomes. Their intended clients include investors interested in the health and technology sectors. LogevityTech.fund emphasizes the importance of enhancing life quality through advanced technological solutions.
i&i Biotech Fund
Undisclosed investor participating in the funding round.
Formic Ventures
Undisclosed investor participating in the funding round.
What's next for Sampling Human?
With its recent major strategic investment, Sampling Human is poised to accelerate the development and commercialization of its innovative diagnostic technologies. The substantial capital infusion, part of its overall $2M in funding, will likely fuel further research and development, expand its market reach, and enhance its proprietary "Diagnostics On Target" platform. This strategic financing suggests a company in a scaling phase, aiming to solidify its position in the competitive synthetic biology and diagnostics market by bringing its advanced early disease detection solutions to a wider audience.
See full Sampling Human company page
